Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Th1 Response to Influenza Vaccine in Aging
NCT00396305Phase 4Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2006
- Primary completion
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent inactivated influenza vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2006; status: terminated.
02
Drugs
trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00396305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396305.